{"transactions":[{"id":770126,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:30:31.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":45887,"price":0.8967,"value":41146.8729,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares of Common Stock sold under an automated program to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person.  This sale was mandated by the Issuer's practice to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction pursuant to a plan entered into by the Reporting Person for the purchase or sale of equity securities of the Issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and therefore does not represent a discretionary sale by the Reporting Person."}],"balance_after":272713,"source":{"system":"sec-edgar","filing":"0001916853-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000191685326000002/ownership.xml","form_type":"4"}},{"id":997891,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-17T22:51:24.000Z","date":"2025-11-16","kind":"grant","planned":false,"acquired":true,"shares":311100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027."}],"balance_after":318600,"source":{"system":"sec-edgar","filing":"0001628280-25-052720","document":"wk-form4_1763419881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000162828025052720/wk-form4_1763419881.xml","form_type":"4"}},{"id":1172635,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-14T13:00:12.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":1.55,"value":11625.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001818382-25-000049","document":"wk-form4_1744635605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000049/wk-form4_1744635605.xml","form_type":"4"}},{"id":1296470,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-01-23T21:34:03.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":283101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through  January 21, 2029."}],"balance_after":283101,"derivative":{"exercise_price":4.56,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":283101},"source":{"system":"sec-edgar","filing":"0001818382-25-000015","document":"wk-form4_1737668036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000015/wk-form4_1737668036.xml","form_type":"4"}},{"id":1714463,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-12T21:10:08.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":283000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2024, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2027."}],"balance_after":283000,"derivative":{"exercise_price":2.8,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":283000},"source":{"system":"sec-edgar","filing":"0001818382-23-000195","document":"wk-form4_1702415399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000195/wk-form4_1702415399.xml","form_type":"4"}},{"id":2089847,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-12T21:13:56.000Z","date":"2022-12-08","kind":"grant","acquired":true,"shares":91120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026."}],"balance_after":91120,"derivative":{"exercise_price":3.07,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":91120},"source":{"system":"sec-edgar","filing":"0001818382-22-000198","document":"wf-form4_167087961711138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000198/wf-form4_167087961711138.xml","form_type":"4"}},{"id":2304816,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":45697,"kind":"person","name":"Parikh Shamik J","position":1,"cik":"0001916853","reported_name":"Parikh Shamik J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-04-05T20:40:31.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":144927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on April 4, 2023, after which 1/48 of the option will become exercisable on the 4th of each month through August 4, 2026."}],"balance_after":144927,"derivative":{"exercise_price":6.9,"exercise_date":"2023-04-04","expiration_date":"2032-04-04","underlying":"Common Stock","underlying_shares":144927},"source":{"system":"sec-edgar","filing":"0001818382-22-000023","document":"wf-form4_164919121747205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000023/wf-form4_164919121747205.xml","form_type":"4"}}]}